You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. A GREEN AND UNIQUE THERMOSETTING-THERMOPLASTIC POLYCARBONATE

    SBC: INSTRUMENTAL POLYMER TECHNOLOGIES, LLC            Topic: 16NCER2B

    Of the 300 million tons of plastic produced per year most will require 500 years to biodegrade. Currently only 9% is recycled, and 50 million tons of thermoset plastic produced annually that can't be recycled. _x000D_ _x000D_ This project will develop a sustainable and easily biodegradable polycarbonate plastic that is uniquely a recyclable thermoset resin. We call it a thermosetting thermoplastic ...

    SBIR Phase II 2018 Environmental Protection Agency
  2. Mobile Analytical Platform for Lead Detection in Drinking Water

    SBC: NANOSAFE, INC.            Topic: 16NCER4C

    The drinking water crisis in Flint, Michigan reminds us that lead remains dangerous and insidious toxicant that can impact public health for months or years before it is detected and remedied.Increasing awareness of lead contamination has motivated the general public to test their own drinking water, but few tools are availiable to help these "citizen scientist" do so effectively.Current lead scre ...

    SBIR Phase II 2018 Environmental Protection Agency
  3. Development of Innovative Broad-Spectrum Analysis Methods for PFAS

    SBC: SEACOAST SCIENCE, INC.            Topic: 17NCER3A

    This SBIR addresses EPA’s need for improved sampling and analysis technologies to detect Per- and Polyfluoroalkyl Substances (PFAS). PFAS are used in firefighting sprays, at airports, and for wild fires, and have been used in textile treatments (e.g., it is a component in Scotchgard). It is estimated that 65 million Americans are at risk of PFAS exposure in their drinking water. Seacoast propose ...

    SBIR Phase I 2018 Environmental Protection Agency
  4. Renewable Bioplastics Production

    SBC: Altex Technologies Corporation            Topic: 17NCER5A

    Altex’s Renewable Bioplastics Production (RBP) technology meets the Greener Plastic Manufacturing needs; to eliminate harmful-petrochemical feed sources, to accomplish toxic-free, low-energy, low cost bioplastics production, to reduce Green House Gas (GHG) emissions, and to have environment friendly-biodegradable bioplastics. Altex’s proposed RBP technology combines a novel feeding-sizing-pret ...

    SBIR Phase I 2018 Environmental Protection Agency
  5. Greener Plastics with High Heat Tolerance for Additive Manufacturing

    SBC: Intelligent Optical Systems, Inc.            Topic: 17NCER5B

    Advances in materials and automation are rapidly reshaping the American manufacturing economy. These advances must be embraced to sustain a strong manufacturing sector in the United States. Additive manufacturing is possibly the fastest growing example of this trend, growing at an astonishing compound annual growth rate of 25.7%. The plastic materials market for additive manufacturing, valued at $ ...

    SBIR Phase I 2018 Environmental Protection Agency
  6. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  7. Bioinformatics: Data Integration for Biomonitoring Applications

    SBC: Arete Associates            Topic: DTRA162002

    Aret Associates and Oak Ridge National Laboratory (ORNL) propose an interdisciplinary effort to further develop and validate a robust, operational biomonitoring application that can process soil microbiome data to reliably detect episodic and low-level chronic contamination while maintaining low false alarm rate.The Phase II SBIR work will build upon the successful Phase I proof-of-concept demonst ...

    SBIR Phase II 2018 Department of DefenseDefense Threat Reduction Agency
  8. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  9. Virus-Like Particle Based pan-Marburgvirus Vaccine

    SBC: Luna Innovations Incorporated            Topic: CBD18A002

    Marburg virus (MARV) is a filamentous enveloped non-segmented negative sense RNA virus. This viruse is considered to be extremelydangerous with case fatality rates as high as 88-90%. Extensive efforts have gone towards effective vaccines for MARV prevention, however,none have been successfully established as licensed vaccines. Glycoprotein (GP) is the only surface protein of MARV. There are substa ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  10. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government